Board of Governors of the Stock Exchange of Thailand (SET) Re: Disclosure of Information of Listed Company Concerning the Connected Transactions B.E. 2546 (2003), the details of which are as follows: Unit
Page 1 No. CMC Sor Lor.009/2019 May 14, 2019 Re: Management Discussion & Analysis for the Period Ended 31 March 2019 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
Page 1 No. CMC Sor Lor.012/2019 August 13, 2019 Re: Management Discussion & Analysis for the Period Ended 30 June 2019 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN
Exchange of Thailand (“SET”) in compliance with conditions of disclosing investment information, including information on asset acquisition transaction and related transactions as per the rules, regulations
No. WPH-SET 9/2019 August 9, 2019 Subject : The expansion of Wattanapat Samui Hospital project To : Director and Manager The Stock Exchange of Thailand Enclosure: The Acquisition and Disposition of
into related party transactions and to disclose information as prescribed in the Notification of the Stock Exchange of Thailand (SET) Re: Disclosure of Information and Other Acts of Listed Companies
process as follows: 1. Disclose the information memorandum on entering into such transaction to the Stock Exchange of Thailand (“SET”) which contained information at least as Class (1) transaction
company; (b) trade units listed on SET for clients through a member of SET (4) brokerage, dealing or underwriting of debt securities and sukuk. “ SET ” means the Stock Exchange of Thailand; “ unit ” means